Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Defining the unknown: molecular methods for finding new microbes

E A Wagar1

  • 1Department of Pathology and Laboratory Medicine, UCLA School of Medicine 90095-1732, USA.

Journal of Clinical Laboratory Analysis
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The gene for the S7 ribosomal protein of Chlamydia trachomatis: characterization within the chlamydial sfr operon.

Molecular microbiology·2017
Same author

A cumulative experience examining the effect of natural and synthetic antimicrobial peptides vs. Chlamydia trachomatis.

The journal of peptide research : official journal of the American Peptide Society·2004
Same author

Activity of Novispirin G-10, a novel antimicrobial peptide against Chlamydia trachomatis and vaginosis-associated bacteria.

Experimental and molecular pathology·2003
Same author

Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2000
Same author

Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection.

Infection and immunity·1999
Same author

A comparison of the early inflammatory effects of an agr-/sar- versus a wild type strain of Staphylococcus aureus in a rat model of endophthalmitis.

Current eye research·1999
Same journal

Changes of CEA Diagnostic Performance Under the New Reference Interval Stratified by Age and Sex.

Journal of clinical laboratory analysis·2026
Same journal

Investigation of Specific IgG-Secreting Cells in Congenital Toxoplasmosis: The TOXODIAG Study.

Journal of clinical laboratory analysis·2026
Same journal

Development and Analytical Validation of a Laboratory-Customized TaqMan-MGB Probe Method for CYP2C19 Genotyping.

Journal of clinical laboratory analysis·2026
Same journal

Heavy Metal Mixture Exposure and Insulin Resistance in U.S. Adults: The Mediating Role of Systemic Inflammation.

Journal of clinical laboratory analysis·2026
Same journal

A New Diagnostic Approach Using the NLR/LMR Ratio in the Differential Diagnosis of Neck Masses: Hematologic Evaluation of Patients With Cervical Lymphadenopathy.

Journal of clinical laboratory analysis·2026
Same journal

Elevated Hemoglobin A<sub>2</sub>: A Molecular Revisited, and Implications to β-Thalassemia Screening.

Journal of clinical laboratory analysis·2026
See all related articles

Molecular diagnostics are identifying unknown microbial pathogens using techniques like PCR and reverse PCR (RPA). These methods enhance our understanding of the microbial world and aid in demonstrating pathogen roles in disease.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Microbial pathogens pose significant diagnostic challenges, particularly when unidentified.
  • Understanding the microbial environment is crucial for human health.

Purpose of the Study:

  • To describe applications of molecular diagnostics for identifying microbial pathogens.
  • To highlight techniques for detecting novel and known infectious agents.

Main Methods:

  • Polymerase Chain Reaction (PCR) with specific primers for novel microbe identification.
  • 16S rRNA gene sequencing coupled with internal sequence analysis for bacterial pathogen identification.
  • Reverse hybridization assay (RHA) for identifying unique infectious agents in diseased tissues.

Related Experiment Videos

Main Results:

  • Specific primers and PCR effectively identify new microbes.
  • 16S rRNA sequencing aids in identifying specific bacterial pathogens.
  • Reverse hybridization assay (RHA) detects unique infectious agents in diseased tissues.

Conclusions:

  • Molecular diagnostics are rapidly advancing the identification of microbial pathogens.
  • These techniques improve understanding of human-microbe interactions.
  • Future applications include demonstrating the pathogenesis of newly identified microbes.